Literature DB >> 17211553

Vasovagal syncope in patients with reduced left ventricular function.

Christopher M Stanton1, Phillip A Low, David O Hodge, Win-Kuang Shen.   

Abstract

Vasovagal syncope (VVS) is mediated by arterial mechanoreceptors, resulting in reflexive changes in heart rate and vascular tone. The Bezold-Jarisch reflex was originally described as enhanced contraction and activation of left ventricular mechanoreceptors, but later studies implicated other triggers, including coronary, carotid, and cerebral arterial mechanoreceptors. VVS is uncommon in patients with left ventricular dysfunction. We hypothesized that VVS could occur in this subset and examined patient characteristics and hemodynamic responses during tilt table testing. From 1996 through 1998, 128 consecutive patients with ejection fraction <40% underwent tilt table testing (70 degrees , 45 min). A total of 15 patients (11.7%) had a positive neurocardiogenic response thought to be the cause of syncope. Clinical data and hemodynamic responses were reviewed. Mean patient age (+/-SEM) was 70.1 +/- 12.2 years. Nine patients were male. Mean ejection fraction was 27.7% +/- 7.1%. Thirteen had electrophysiologic studies with normal findings or abnormal findings insufficient to account for syncope. Hemodynamic analysis of 14 patients who had a vasovagal response during passive tilt table testing showed a mean time to positive response of 17.6 +/- 12.7 min. Cardioinhibitory responses (pauses >3 sec or heart rate < 40 beats/min for > or =10 sec) were not observed. Five responses were classified as mixed type (>10% decrease in heart rate without a cardioinhibitory response) and 9 as vasodepressor type (< or =10% decrease in heart rate). VVS occurs in patients who have clinically significant left ventricular dysfunction. Although this study had a small cohort size, the predominantly vasodepressor response without a cardioinhibitory component warrants further investigation into mechanisms of VVS in these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17211553     DOI: 10.1007/s10286-006-0386-8

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  25 in total

1.  Increase of plasma beta endorphins in vasodepressor syncope.

Authors:  G P Perna; U Ficola; M P Salvatori; M Stanislao; C Vigna; A Villella; A Russo; R Fanelli; P G Paleani Vettori; F Loperfido
Journal:  Am J Cardiol       Date:  1990-04-01       Impact factor: 2.778

2.  The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.

Authors:  S J Connolly; R Sheldon; R S Roberts; M Gent
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

3.  Increased activity in left ventricular receptors during hemorrhage or occlusion of caval veins in the cat. A possible cause of the vaso-vagal reaction.

Authors:  B Oberg; P Thorén
Journal:  Acta Physiol Scand       Date:  1972-06

4.  Cardiovascular effects of microinjection of adenosine into the nucleus tractus solitarius.

Authors:  R A Barraco; C J Janusz; P M Polasek; M Parizon; P A Roberts
Journal:  Brain Res Bull       Date:  1988-01       Impact factor: 4.077

5.  Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.

Authors:  R Sutton; M Brignole; C Menozzi; A Raviele; P Alboni; P Giani; A Moya
Journal:  Circulation       Date:  2000-07-18       Impact factor: 29.690

6.  Adenosine: potential modulator for vasovagal syncope.

Authors:  W K Shen; S C Hammill; T M Munger; M S Stanton; D L Packer; M J Osborn; D L Wood; K R Bailey; P A Low; B J Gersh
Journal:  J Am Coll Cardiol       Date:  1996-07       Impact factor: 24.094

7.  Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions.

Authors:  R G Evans; J Ludbrook; A F Van Leeuwen
Journal:  J Physiol       Date:  1989-12       Impact factor: 5.182

8.  Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope.

Authors:  B P Grubb; D A Wolfe; D Samoil; P Temesy-Armos; H Hahn; L Elliott
Journal:  Pacing Clin Electrophysiol       Date:  1993-03       Impact factor: 1.976

9.  Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.

Authors:  Stuart J Connolly; Robert Sheldon; Kevin E Thorpe; Robin S Roberts; Kenneth A Ellenbogen; Bruce L Wilkoff; Carlos Morillo; Michael Gent
Journal:  JAMA       Date:  2003-05-07       Impact factor: 56.272

10.  Cerebral vasoconstriction during head-upright tilt-induced vasovagal syncope. A paradoxic and unexpected response.

Authors:  B P Grubb; G Gerard; K Roush; P Temesy-Armos; P Montford; L Elliott; H Hahn; P Brewster
Journal:  Circulation       Date:  1991-09       Impact factor: 29.690

View more
  3 in total

1.  Vasovagal syncope is associated with poor prognosis in patients with left ventricular dysfunction.

Authors:  Yoshiaki Yamaguchi; Koichi Mizumaki; Kunihiro Nishida; Tamotsu Sakamoto; Yosuke Nakatani; Naoya Kataoka; Koichiro Kinugawa; Hiroshi Inoue
Journal:  Heart Vessels       Date:  2017-11-06       Impact factor: 2.037

2.  Sympathetic nerve activity restrains reflex vasodilatation in heart failure.

Authors:  Maria Janieire N N Alves; Maria Urbana P B Rondon; Amilton C Santos; Rodrigo G Dias; Antonio Carlos P Barretto; Eduardo M Krieger; Holly R Middlekauff; Carlos Eduardo Negrão
Journal:  Clin Auton Res       Date:  2007-11-27       Impact factor: 4.435

3.  A risk prediction score model for predicting occurrence of post-PCI vasovagal reflex syndrome: a single center study in Chinese population.

Authors:  Hai-Yan Li; Yu-Tao Guo; Cui Tian; Chao-Qun Song; Yang Mu; Yang Li; Yun-Dai Chen
Journal:  J Geriatr Cardiol       Date:  2017-08       Impact factor: 3.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.